Cafepharma Today

January 31 2025 - AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Vermont doctors get $2.9M cash, gifts from drugmakers
Yahoo/AP
Thursday, April 16, 2009 - 8:36am
tags:
Pfizer, Merck, Eli Lilly, physician payments
Actavis Said to Shelve Sale Plan as Buyers Balk at Asking Price
Bloomberg
Thursday, April 16, 2009 - 8:35am
tags:
Actavis
Biogen Idec Receives Approval for TYSABRI High Titer Production
Yahoo
Thursday, April 16, 2009 - 8:32am
tags:
Biogen Idec, Tysabri, FDA, MS, multiple sclerosis
Big Pharma still “greatly interested” in China
Pharma Times, UK
Thursday, April 16, 2009 - 8:00am
tags:
Big Pharma, China
Biogen Idec reports 1Q results after the market closes, Wall Street focuses on MS drugs
Yahoo/AP
Thursday, April 16, 2009 - 7:55am
tags:
Biogen Idec, earnings, MS, multiple sclerosis, Tysabri
Baxter 1Q profit rises 20 percent, but sales fall
Yahoo/AP
Thursday, April 16, 2009 - 7:52am
tags:
Baxter International, devices, earnings, Abbott Laboratories, JNJ
Calls Jumping in King Pharmaceuticals
TheStreet.com
Thursday, April 16, 2009 - 7:31am
tags:
King, Embeda, Alpharma
Glaxo, Pfizer in HIV-Drug Unit Tie-Up: Report
TheStreet.com
Thursday, April 16, 2009 - 7:09am
tags:
GSK, Pfizer, HIV, partnerships, joint ventures
Roche beats recession in first quarter
Yahoo/Reuters
Thursday, April 16, 2009 - 7:08am
tags:
Roche, earnings, Genentech
J&J shelves plans for separate wellness unit: report
Yahoo/AP
Thursday, April 16, 2009 - 7:07am
tags:
JNJ
Marked Improvement Bodes Well for Pozen
Seeking Alpha
Wednesday, April 15, 2009 - 10:18pm
tags:
Pozen, Treximet, GSK
Study: Lilly bone drug boosts fracture-healing
Fierce Pharma
Wednesday, April 15, 2009 - 5:40pm
tags:
Eli Lilly, osteoporosis, Forteo
Carl Icahn calls on Amylin chairman to step down
Marketwatch
Wednesday, April 15, 2009 - 5:31pm
tags:
Carl Icahn, Amylin
A Big Upgrade for Forest Labs
Motley Fool
Wednesday, April 15, 2009 - 5:27pm
tags:
Forest Labs, Savella, Cypress Bioscience, Lexapro, Namenda
Abbott's on Sale
Motley Fool
Wednesday, April 15, 2009 - 5:26pm
tags:
Abbott Laboratories, JNJ, Amgen, Wyeth, Boston Scientific
Drug stocks dip; Infinity halted on drug trial news
Marketwatch
Wednesday, April 15, 2009 - 10:02am
tags:
Infinity, drug trials
Merck Exec on R&D: ‘Nothing Is Safe From Cuts’
WSJ Online
Wednesday, April 15, 2009 - 10:00am
tags:
Merck, R&D
Pfizer Top Pharma Social Brand
Media Post
Wednesday, April 15, 2009 - 9:25am
tags:
Pfizer, social media
Cancer pills suffer from red tape
Fierce Pharma
Wednesday, April 15, 2009 - 9:24am
tags:
cancer, insurance
Highlights from Day 1: Pharmaceutical Strategic Outlook Conference
InVivo
Wednesday, April 15, 2009 - 9:10am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information